查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446554

髂動脈支架市場規模、佔有率、趨勢分析報告：按類型、按動脈病變、按最終用途、按地區、按細分市場、預測，2024-2030 年

Iliac Stent Market Size, Share & Trends Analysis Report By Type (Self-expandable Stents, Balloon-expandable Stents), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

髂動脈支架市場成長與趨勢：

Grand View Research, Inc最新報告顯示，到2030年，全球髂支架市場規模預計將達到15.3億美元，預計2024年至2030年複合年成長率為5.8%。

由於周邊動脈疾病盛行率的增加、醫療技術的不斷進步以及人們對微創手術作為心血管疾病有效治療選擇的認知不斷增強等因素，該市場預計將成長。

該行業的成長是由新產品開發和增加的通暢性調整程序所推動的。例如，自動擴張型支架在治療髂外動脈方面已顯示出優異的效果。此外，周邊動脈疾病（PAD）盛行率的增加預計將推動髂支架市場的成長。根據健康指標與評估研究所 2023 年 10 月的一篇報導，全球 PAD 盛行率為 1.52%，約 1.13 億人。此外，2022 年 NCBI 的一篇論文預測，PAD 的年發生率將接近 1,000 萬人。

髂支架主要參與者之間不斷增加的策略性舉措預計將推動成長。例如，2024年1月，Zylox-Tonbridge醫療科技有限公司的周邊靜脈支架系統獲得國家藥品監督管理局（NMPA）的上市核准。此外，2023 年 10 月，Getinge AB 宣布用於治療髂動脈阻塞性疾病的 iCast 覆膜支架系統在美國上市。

髂動脈支架市場報告亮點

  • 醫療保健產業的髂支架市場預計到2023年將達到10.3億美元，預計2030年將達到15.3億美元。
  • 預計2024年至2030年，髂骨支架市場將以5.8%的年複合成長率成長，2030年將達到15.3億美元。
  • 2023年，北美佔據髂支架市場最大佔有率，銷售佔有率為43.7%。美國易患 PAD 的老年人口的增加預計將增加對支架置入術的需求，並在預測期內顯著促進市場成長。
  • 按支架類型分類，自動擴張型支架在 2023 年佔據最大的銷售佔有率，達到 60.4%，因為這些支架的積極的長期臨床試驗結果預計將為醫療保健提供者提供信心。這是有原因的。
  • 按動脈病變分，2023年髂總動脈病變細分市場銷售佔有率最大，為60.5%。由於患有高膽固醇和肥胖症的患者數量不斷增加，預計對髂支架的需求將會增加。
  • 以最終用途計算，到 2023 年，醫院細分市場將佔銷售額的壓倒性 61.7%。該醫院作為轉診中心，患者接受綜合治療，包括診斷影像、醫療管理和介入手術（如髂骨支架置入術）。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 Ilial 支架市場：變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 髂動脈支架市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 髂動脈支架市場：類型估算與趨勢分析

  • 髂動脈支架市場：型式儀表板
  • 髂動脈支架市場：類型變化分析
  • 髂動脈支架市場規模（按類型）、預測和趨勢分析，2018-2030 年
  • 自動擴張型支架
  • 球囊擴張型支架
  • 其他

第5章 髂動脈支架市場：動脈病變預估及趨勢分析

  • 髂動脈支架市場：動脈病變儀表板
  • 髂動脈支架市場：動脈病變的變化分析
  • 髂動脈支架市場規模（按動脈病變）、預測和趨勢分析，2018-2030 年
  • 髂總動脈病變
  • 鈣化病變
  • 完全阻塞性病變

第6章髂動脈支架市場：最終用途估計與趨勢分析

  • 髂動脈支架市場：最終用途儀表板
  • 髂動脈支架市場：最終用途變化分析
  • 髂動脈支架市場規模（按最終用途、預測和趨勢分析），2018-2030 年
  • 醫院
  • 門診設施
  • 其他

第 7 章 髂動脈支架市場：區域估計和趨勢分析，按國家、按類型、按動脈病變、按最終用途

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • BD
    • Abbott
    • Boston Scientific Corporation
    • WL Gore & Associates, Inc.
    • Cook
    • Medtronic
    • Vascular
    • Terumo Corporation
    • Getinge AB
    • Biotronik SE &Co KG
Product Code: GVR-4-68040-206-4

Iliac Stent Market Growth & Trends:

The globall iliac stent market size is expected to reach USD 1.53 billion by 2030, projected to grow at a CAGR of 5.8% from 2024 to 2030, based on a new report by Grand View Research, Inc. The market is expected to grow due to factors such as the increasing prevalence of peripheral artery diseases, growing advancements in medical technology, and expanding awareness about minimally invasive procedures as an effective treatment option for cardiovascular diseases.

The industry's growth is driven by new product development and aligned procedures with enhanced patency. For instance, self-expanding stents have demonstrated exceptional results in the treatment of external iliac artery. Furthermore, the growing prevalence of peripheral artery disease (PAD) is expected to propel iliac stents market growth. According to an article by the Institute for Health Metrics and Evaluation in October 2023, the global prevalence of PAD was pegged at 1.52% or nearly 113 million people. Additionally, NCBI's article in 2022 projected the annual incidence of PAD to be nearly 10 million.

An increase in strategic initiatives amongst the key players of iliac stents is anticipated to propel growth. For instance, in January 2024, Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from the National Medical Products Administration (NMPA) for its peripheral venous stent system. Furthermore, in October 2023, Getinge AB announced the commercial availability of its product, iCast covered stent system to treat iliac arterial occlusive disease in the U.S.

Iliac Stents Market Report Highlights:

  • The iliac stents marketin the healthcare industry was estimated at USD 1.03 Billion in 2023 and is expected to reach USD 1.53 Billion in 2030
  • The iliac stents marketis expected to grow at a compound annual growth rate of 5.8% from 2024 to 2030 to reach USD 1.53 Billion by 2030
  • In 2023, North America held the largest share in the iliac stents market, with a revenue share of 43.7%. The growing geriatric population in the U.S., which is susceptible to PAD is expected to increase the demand for stenting procedures, thereby significantly contributing to the market growth over the forecast period
  • By type, self-expandable stents segment accounted for the largest revenue share of 60.4% in 2023driven by favorable long-term clinical study results for these stents that are expected to instill confidence in healthcare providers
  • By artery lesions, the common iliac artery lesions segment accounted for the largest revenue share of 60.5% in 2023 driven by growing cases of patients suffering from high cholesterol and obesity are expected to boost the demand for iliac stents, as these conditions cause plaque buildup, which narrows or blocks artery lumen
  • By end use, hospital segment accounted for a dominant revenue share of 61.7% in 2023. Hospitals serve as referral centers where patients receive comprehensive care, including diagnostic imaging, medical management, and interventional procedures like iliac stent placement

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Artery lesions
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for Primary Interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Parent market analysis (Model 2)
    • 1.7.4. Approach 2: Parent market analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment outlook
    • 2.2.1. Type outlook
    • 2.2.2. Artery lesions outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Iliac Stents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of peripheral artery disease (PAD)
      • 3.2.1.2. Technological advancements in iliac stents
      • 3.2.1.3. Increasing number of product approvals in developed and developing countries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of reimbursement policies for venous stenting
      • 3.2.2.2. Product recalls
  • 3.3. Iliac Stents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Iliac Stents Market: Type Estimates & Trend Analysis

  • 4.1. Iliac Stent Market: Type Dashboard
  • 4.2. Iliac Stent Market: Type Movement Analysis
  • 4.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Self-Expandable Stents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Balloon-Expandable Stents
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Iliac Stents Market: Artery Lesions Estimates & Trend Analysis

  • 5.1. Iliac Stent Market: Artery Lesions Dashboard
  • 5.2. Iliac Stent Market: Artery Lesions Movement Analysis
  • 5.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Artery Lesion, 2018 to 2030 (USD Million)
  • 5.4. Common Iliac Artery Lesions
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Severe Calcified Lesions
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Complete Obstructive Lesions
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Iliac Stents Market: End-Use Estimates & Trend Analysis

  • 6.1. Iliac Stent Market: End-Use Dashboard
  • 6.2. Iliac Stent Market: End-Use Movement Analysis
  • 6.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Outpatient Facilities
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Iliac Stents Market: Regional Estimates & Trend Analysis by Country, Type, Artery Lesions, & End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa Market Estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Abbott
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Boston Scientific Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. W. L. Gore & Associates, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cook
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Medtronic
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Vascular
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Getinge AB
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Biotronik SE & Co KG
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 5 North America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 8 U.S. Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 11 Canada Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 15 Europe Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 18 Germany Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 21 UK Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 23 France Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 24 France Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 27 Italy Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 30 Spain Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 33 Denmark Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 36 Sweden Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 39 Norway Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 45 China Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 46 China Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 49 Japan Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 51 India Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 52 India Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Korea Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 55 South Korea Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 58 Australia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 61 Thailand Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 63 Latin America Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 65 Latin America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Brazil Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 68 Brazil Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 71 Mexico Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 74 Argentina Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 76 MEA Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 78 MEA Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 81 South Africa Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 87 UAE Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Iliac Stents market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Iliac Stents Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and artery lesions segment snapshot
  • Fig. 10 End-use segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Market dynamics
  • Fig. 13 Prevalence of PAD in 2022, by WHO regions
  • Fig. 14 Porter's Five Forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Iliac Stents market: Type outlook and key takeaways
  • Fig. 17 Iliac Stents market: Type movement analysis
  • Fig. 18 Self-expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Balloon expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Iliac Stents market: Artery Lesions outlook and key takeaways
  • Fig. 22 Iliac Stents market: Artery Lesions movement analysis
  • Fig. 23 Common Iliac Artery Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Severe Calcified Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Complete Obstructive Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Iliac Stents market: End-use outlook and key takeaways
  • Fig. 27 Iliac Stents market: End-use movement analysis
  • Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Outpatient Facilities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Iliac Stents market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways (1/2)
  • Fig. 33 Regional marketplace: Key takeaways (2/2)
  • Fig. 34 North America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Rest of Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Reimbursement scenario
  • Fig. 60 Japan Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Regulatory framework
  • Fig. 63 Reimbursement scenario
  • Fig. 64 China Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Reimbursement scenario
  • Fig. 67 India Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Australia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Korea Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Malaysia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Vietnam Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Philippines Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Rest of Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Brazil regulation details
  • Fig. 84 Reimbursement scenario
  • Fig. 85 Brazil Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina pharmaceuticals registration details
  • Fig. 88 Argentina Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Regulatory framework
  • Fig. 91 Reimbursement scenario
  • Fig. 92 Mexico Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Rest of Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Saudi Arabia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 UAE Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Kuwait Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Rest of MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Company market share analysis, 2023
  • Fig. 106 Strategic Framework